Parsing Science: The Unpublished Stories Behind The Worlds Most Compelling Science, As Told By The Researchers Themselves.

How could a gene that causes one type of ALS be switched off? In episode 87, Tim Miller from the Washington University in St. Louis discusses his research into therapies that target the single strands of DNA or RNA which cause many cases of amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig's disease. His article “Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS” was published with multiple co-authors on July 9th 2020 in the New England Journal of Medicine.  Silencing an ALS Gene - Tim MillerSilencing an ALS Gene - Tim MillerSilencing an ALS Gene - Tim Miller Silencing an ALS Gene - Tim MillerSilencing an ALS Gene - Tim MillerSilencing an ALS Gene - Tim Miller {{svg_share_icon}}Click bottom of waveform to add your commentsSubscribe: iTunes | Google Podcasts | Google Play | Spotify | RSS jQuery(document).ready(function ($){var settings_ap7669 = { design_skin: "skin-wave" ,autoplay: "off",disable_volume:"default" ,loop:"off" ,cue: "on" ,embedded: "off" ,preload_m